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Dialysis fluids and monocytes: Suicide or murder?
Continuous ambulatory peritoneal dialysis is a common
procedure that frees some patients from constant depen-
dence on hemodialysis centers. It is not without risk,
especially that of infection, which can be catastrophic. Does
the procedure itself impair local scavenger and immune
function? After all, when one places a foreign solution into
the peritoneum, the cells in contact with it may have their
function or their very survival compromised. It is this
question which Joerg Plum and colleagues address in this
issue of Kidney International [1]. There are a number of
ways in which the effects of peritoneal dialysis solutions on
cellular function might be investigated, and here peripheral
blood monocytes were chosen as a stand-in for resident
peritoneal macrophages. This is reasonable, since it would
be impossible to harvest human peritoneal cells with each
of the test solutions, which are not approved in their tested
form for in vivo use. Instead, fresh monocytes were incu-
bated in a variety of solutions for 15 minutes, and then
diluted with the most popular tissue culture medium,
RPMI 1640, supplemented with fetal calf serum, which
provides multiple growth factors. A number of tests were
performed on the cells after a further 16 hours of incuba-
tion at 37°C. The authors feel that this is a reasonable
model because, as they point out, the fluid in the perito-
neum will equilibrate towards the composition of normal
tissue fluid (with respect to pH and osmolality, at least) in
about this time frame. Although not a perfect representa-
tion of what must go on in the body, it seems to me that this
model would be useful at least for identifying solutions that
are particularly good or bad at maintaining monocyte
function. The solutions tested differed in their buffer
(bicarbonate, phosphate, or lactate) and their energy
source/osmolite (glucose, dextrin, or amino acids), as well
as pH (lactate-buffered solutions were tested at both pH
5.5 and 7.5). Not every combination was tested, nor were
mixed solutions, for example, ones containing both glucose
and amino acids.
Further tests with a more systematic range of composi-
tions are still needed. In all cases, comparisons were made
to cells incubated 16 hours in RPMI 1640; values for this
control were set to 100%. This makes the assumption that
RPMI is the perfect medium, maintaining cells for 16
hours in peak condition, but it would have been useful to
know what all values were when the cells were fresh.
Viability was determined by a test of mitochondrial
function, which showed that the lactate buffered solu-
tions were least able to maintain viability, while glucose-
bicarbonate and amino acid-bicarbonate were the best.
This pattern repeated in a number of functional studies.
Perhaps the most interesting is the examination of the
mode of monocyte death. Hematopoietic cells, like most
others in the body, die by necrosis or apoptosis [2]. Necrosis
is a violent sort of death, which follows abrupt, irreparable
injury. It is sometimes likened to murder. Apoptosis, on the
other hand, is suicide; it is a physiological process that cells
can do to themselves when so signaled by other cells, by a
change in their environment, when they reach a certain age,
or when they are more mildly injured. Why would an
injured cell want to commit suicide? Because its injury, if
inaccurately repaired, might lock in a dangerous mutation.
Lymphocytes are very ready to undergo apoptosis on the
slightest injury, because if they go wrong, their propensity
for rapid division represents a very significant threat to the
body. Monocytes are less threatening, and as nicely dem-
onstrated in the paper by Plum et al, they do not undergo
apoptosis to any interesting extent under the experimental
conditions (no solution induced more apoptosis than the
“background” level of 20% seen with RPMI 1640). How-
ever, the lactate buffered solutions produced excessive
death by necrosis. This is perhaps not surprising, as the
concentration of lactate in the test solutions is about four
times that achieved in the blood of healthy people at
maximal exertion [3]. The method used to distinguish
necrosis from apoptosis is worthy of examination, as it is
very elegant indeed. In apoptosis, well before cells die the
membrane becomes rearranged, and one of the phospho-
lipids, phosphatidylserine, moves to the outer layer from its
normal confinement within the cell [4]. Thus exposed, it can
be detected with fluorescently-labeled annexin V [5]. Cells
were also treated with propidium iodide, which bound to
the DNA double helix, becoming fluorescent, but it could
only penetrate cells whose membrane had become perme-
able in death. The flow cytometer distinguished annexin
and propidium fluorescence, and displayed each on a
separate axis (Fig. 2 of [1]). With RPMI 1640, most cells
were negative for both stains, that is, normal. Some were
annexin positive but propidium negative (sector III), that is,
they were apoptotic but not yet dead. Necrotic cells were
both permeable (propidium positive) and their membrane
was disrupted (annexin positive) so they displayed in sector
I. In the most toxic glucose-lactate condition, the flow
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cytometer diagram showed a dramatic sweep of cells into
this sector.
RPMI 1640 was developed in Buffalo, New York, at
Roswell Park Memorial Institute (hence the acronym) by
George Moore [6]. It has become the medium of choice for
both mouse and human hematopoietic cells. Since it was
clearly best at preserving cell viability and function of all
tested solutions, one wonders why it is not used for
peritoneal dialysis. The main reason must be cost; it is a
very complex mixture (at least 40 ingredients), and a liter
sells for $16 US at wholesale. If one examines the contents
[7] it seems to be an average of the solutions tested. That is,
it contains glucose, amino acids, and bicarbonate; further-
more, its osmolality is close to physiological. Given the
results presented in the interesting study by Plum et al, it
seems clear which direction further research in peritoneal
dialysis fluids should take.
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